Literature DB >> 17525167

Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.

Lawrence Rice1, Marcie J Hursting, G Mark Baillie, David A McCollum.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17525167     DOI: 10.1177/0091270007302951

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  7 in total

1.  Clinical experience with argatroban for heparin-induced thrombocytopenia in a large teaching hospital.

Authors:  Duane Bates; Sarah Griffin; Barb Angel
Journal:  Can J Hosp Pharm       Date:  2009-07

Review 2.  Argatroban in the management of heparin-induced thrombocytopenia.

Authors:  Luciano Babuin; Vittorio Pengo
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

Review 3.  Effect of obesity on the pharmacokinetics of drugs in humans.

Authors:  Michael J Hanley; Darrell R Abernethy; David J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

4.  Dosing patterns and outcomes in African American, Asian, and Hispanic patients with heparin-induced thrombocytopenia treated with argatroban.

Authors:  Marcie J Hursting; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2008-11-19       Impact factor: 2.300

5.  Effect of body mass index on Argatroban therapy during percutaneous coronary intervention.

Authors:  Marcie J Hursting; Ik-Kyung Jang
Journal:  J Thromb Thrombolysis       Date:  2007-05-28       Impact factor: 2.300

Review 6.  Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.

Authors:  Marcie J Hursting; Joseph Soffer
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

7.  Cost-effectiveness of anticoagulants for suspected heparin-induced thrombocytopenia in the United States.

Authors:  Ahmed Aljabri; Yvonne Huckleberry; Jason H Karnes; Mahdi Gharaibeh; Hussam I Kutbi; Yuval Raz; Seongseok Yun; Ivo Abraham; Brian Erstad
Journal:  Blood       Date:  2016-10-28       Impact factor: 22.113

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.